Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa
- PMID: 20559040
- DOI: 10.1097/QAD.0b013e32833a2520
Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa
Abstract
Objectives: We aimed to compare the incidence of meningococcal disease amongst HIV-infected and uninfected individuals and to evaluate whether HIV is a risk factor for mortality and bacteremia amongst patients with meningococcal disease.
Design: Cohort surveillance study.
Methods: We conducted laboratory-based surveillance for meningococcal disease in Gauteng Province, South Africa. HIV status and outcome data were obtained at sentinel sites. Incidence in HIV-infected and uninfected persons was calculated assuming a similar age-specific HIV prevalence in tested and untested individuals. Risk factors for death and bacteremia (as compared with meningitis) were evaluated using multivariable logistic regression.
Results: From 2003 to 2007, 1336 meningococcal cases were reported. Of 504 patients at sentinel sites with known outcome, 308 (61%) had HIV serostatus data. HIV prevalence amongst cases of meningococcal disease was higher than the population HIV prevalence in all age groups. The incidence of meningococcal disease in HIV-infected individuals was elevated in all age groups with an age-adjusted relative risk of 11.3 [95% confidence interval (CI) 8.9-14.3, P < 0.001]. The case-fatality ratio (CFR) was 20% (27/138) amongst HIV-infected and 11% (18/170) amongst HIV-uninfected individuals [odds ratio (OR) 2.1, 95% CI 1.1-3.9]. On multivariable analysis, CFR was greater amongst patients with bacteremia (35%, 29/82) compared with meningitis (7%, 16/226) (OR 7.8, 95% CI 3.4-17.7). HIV infection was associated with increased odds of bacteremia (OR 2.7, 95% CI 1.5-5.0).
Conclusion: HIV-infected individuals may be at increased risk of meningococcal disease. The increased CFR in HIV-infected patients may be explained by their increased odds of bacteremia compared to meningitis.
Similar articles
-
Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa.Clin Infect Dis. 2008 Feb 1;46(3):377-86. doi: 10.1086/525260. Clin Infect Dis. 2008. PMID: 18181736
-
Neonatal meningococcal disease in the United States, 1990 to 1999.Pediatr Infect Dis J. 2003 May;22(5):418-22. doi: 10.1097/01.inf.0000066876.77453.04. Pediatr Infect Dis J. 2003. PMID: 12792381
-
The burden of hospitalizations for meningococcal infection in Spain (1997-2008).Vaccine. 2011 Aug 5;29(34):5765-70. doi: 10.1016/j.vaccine.2011.05.089. Epub 2011 Jun 12. Vaccine. 2011. PMID: 21664402
-
Epidemiology and meningococcal serogroup distribution in the United States.Clin Pediatr (Phila). 2010 Jun;49(6):519-24. doi: 10.1177/0009922809347797. Clin Pediatr (Phila). 2010. PMID: 20507868 Review. No abstract available.
-
2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal disease.Travel Med Infect Dis. 2010 Mar;8(2):68-73. doi: 10.1016/j.tmaid.2010.04.004. Travel Med Infect Dis. 2010. PMID: 20478511 Review.
Cited by
-
Clinical and Microbiological Features of Salmonella Meningitis in a South African Population, 2003-2013.Clin Infect Dis. 2015 Nov 1;61 Suppl 4(Suppl 4):S272-82. doi: 10.1093/cid/civ685. Clin Infect Dis. 2015. PMID: 26449942 Free PMC article. Review.
-
Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016.Clin Infect Dis. 2019 Jul 18;69(3):495-504. doi: 10.1093/cid/ciy914. Clin Infect Dis. 2019. PMID: 30351372 Free PMC article.
-
Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.Hum Vaccin Immunother. 2018 May 4;14(5):1107-1115. doi: 10.1080/21645515.2017.1412020. Epub 2018 Jan 16. Hum Vaccin Immunother. 2018. PMID: 29211624 Free PMC article. Review.
-
Meningitis in HIV-positive patients in sub-Saharan Africa: a review.J Int AIDS Soc. 2014 Oct 10;17(1):19184. doi: 10.7448/IAS.17.1.19184. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25308903 Free PMC article. Review.
-
Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus.J Pediatr. 2012 Oct;161(4):676-81.e2. doi: 10.1016/j.jpeds.2012.04.005. Epub 2012 May 22. J Pediatr. 2012. PMID: 22622049 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical